|Institution||The University of Liverpool|
Dr Greenhalf has been the lead scientist of the European Registry of Hereditary Pancreatitis and Familial Pancreatitis (EUROPAC) since 1997.
Bill sits on various trial steering committee. Including the EUROPAC2 trial (anti-oxidants and magnesium for the treatment of pancreatitis). The Vandetanib in Pancreatic Cancer (VIP) Trial and The European Study Group for Pancreatic Cancer (ESPAC, trials of adjuvant therapy in pancreatic cancer) Tissue group.
Bill sits on the Cancer Research UK Quality Assurance and Translational Science (QATS) Steering Committee and the Confederation of UK Biobanks UK Working Group for Harmonisation, Standardisation and Benchmarking of Biobanks. Bill is part of the NIHR Pancreatic Biomedical Research Unit (PBRU) and is the Operational Director of the Liverpool GCLP facility
Bill is part of the COST Action BM1204 EU_Pancreas